The American company “Moderna” announced that clinical tests on its vaccine against the Coronavirus will not show their results before next November 25, excluding any commercial marketing of the vaccine before the presidential elections.
“We will have enough safety data on November 25 to be able to submit an emergency request to the Food and Drug Administration, provided that the safety data are good, that is, the vaccine is considered safe,” Moderna General Manager Stephan Bancel said during a conference organized by the Financial Times. .
Moderna, in addition to Pfizer and Johnson & Johnson, is conducting the third phase of clinical trials on experimental vaccines for the virus, during which tens of thousands of volunteers are injected with the vaccine and a similar number with a placebo vaccine, to verify the vaccine’s effectiveness and safety.
There is a fourth vaccine in the United States that reached this third stage, but clinical trials on it were temporarily suspended. It is a vaccine developed by the “AstraZeneca” company in cooperation with the University of Oxford.
US President Donald Trump has expressed many times his hope that a vaccine will be found before the upcoming November 3 elections, which has raised health experts’ fears of putting political pressure on the regulatory process for adopting vaccines.
These were the details of the news No vaccine against Corona before the US elections? for this day. We hope that we have succeeded by giving you the full details and information. To follow all our news, you can subscribe to the alerts system or to one of our different systems to provide you with all that is new.
It is also worth noting that the original news has been published and is available at saudi24news and the editorial team at AlKhaleej Today has confirmed it and it has been modified, and it may have been completely transferred or quoted from it and you can read and follow this news from its main source.
